Fidelity Select Biotechnology Portfolio Current Cash

Fidelity Select Biotechnology Portfolio (FBIOX) currently reports a current cash of $200K as of September 2023. That compares with $610K in the prior-year period — down 67.7% year over year. Use the charts on this page to explore Fidelity Select Biotechnology Portfolio's current cash history and peer comparisons.

Fidelity Select Biotechnology Portfolio's current cash decreased from $610K to $200K — a 67.7% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Fidelity Select Biotechnology Portfolio reported $200K in current cash as of September 2023. That compares with $610K in the prior-year period — down 67.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $200K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fidelity Select Biotechnology Portfolio, and consider following FBIOX for alerts when major investors trade the stock.